The company has added state-of-the-art equipment that will further enhance manufacturing functionality and capability
Research Triangle Park, North Carolina – September 17, 2014 – Tergus (www.terguspharma.com) has acquired cutting-edge equipment that will aid in manufacturing topical pharmaceutical supplies for clinical trials. The company, currently working from a state-of-the-art facility at Research Triangle Park area of Durham, North Carolina, delivers topical pharmaceutical formulation, analytical R&D, IVRT testing and manufacturing. Tergus has a stellar, 18-year track record of successfully providing comprehensive services as well as regulatory guidance, documentation and support.
“We are excited to be furthering the functionality of our cGMP clinical supplies manufacturing operation,” said Vijendra Nalamothu, PhD, CEO and co-founder of Tergus. “Our clients are our objective; this new equipment will ensure that our clients are getting the best we can provide through the entire process of research, development, analysis, testing and manufacturing. The goal is to deliver clinical supplies on a fast track to meet client’s clinical study requirement and tight timelines.”
The new machinery includes four different turboemulsifiers, ranging from 2 kg to 150kg capacity, a microfluidizer processor and several packaging equipment pieces. This top-of-the-line equipment will enhance the company’s manufacturing as well as deliver the most positive outcomes. From mixing stable creams and emulsions to achieving uniform particle size reduction to package the product in multiple configurations, these machines will guarantee accuracy and efficacy in producing supplies for clinical trials.
Tergus offers topical pharmaceutical formulation, analytics, In Vitro Release Testing (IVRT), skin biology and clinical supplies manufacturing GMP laboratories. The company also has several banks of IVRT and skin penetration cells and advanced clean-room environments Tergus Pharma’s services range from formulation through testing and manufacturing. The company leads the pack in topical pharmaceutical services.